DETROIT, Aug. 28, 2024 /PRNewswire/ -- AcariaHealth, a national specialty pharmacy focused on improving care and outcomes for patients living with complex medical conditions and a Centene company (NYSE: CNC), announced the relocation of its Homescripts pharmacy, a national leader in free goods service supporting patient medication access and adherence, to Shelby Township, Michigan. This new, nearly 33,000 square foot Detroit-area facility will provide ample space for business and pharmacy operations.
"We believe that investing in our employees and the communities we serve is integral to improving health outcomes and enhancing quality of life," said Chief Executive Officer of AcariaHealth, Jessica Ciccolella-Kahl. "We are grateful for the opportunity to contribute to the vibrant Shelby Township community and look forward to utilizing this beautiful new facility to support patients across the country."
Homescripts offers manufacturer-led medication programs for Patient Assistance, Bridge, Interim, and Replacement services that help patients overcome adherence barriers including medication costs, insurance coverage, and medication loss, theft, or expiration. Homescripts pharmacists and staff are devoted to helping patients enrolled in free goods programs for conditions such as, but not limited to, multiple sclerosis, Alzheimer's disease, and myasthenia gravis. Homescripts works closely with patients and providers to help manage the daily impact of their conditions and reduce barriers, leading to improved adherence and better health outcomes.
The opening of this new facility underscores AcariaHealth's commitment to transforming lives with compassionate care through exceptional services and leading innovation. The modern inviting workspaces and upgraded dispensing pharmacy provides ample space for future growth and expansion capabilities to meet patient and client needs.
About AcariaHealth
AcariaHealth is a national specialty pharmacy focused on improving care and outcomes for patients living with complex medical conditions and transforming lives with compassionate care. As a Centene company, AcariaHealth has the unique ability to leverage the comprehensive solutions of the largest Medicaid managed care organization in the country. Visit AcariaHealth.com to learn more about how we provide exceptional specialty pharmacy services and superior patient care.
| Last Trade: | US$76.24 |
| Daily Change: | -0.08 -0.10 |
| Daily Volume: | 1,374,691 |
| Market Cap: | US$40.100B |
September 11, 2024 August 29, 2024 July 26, 2024 | |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
